Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yestar Healthcare Holdings CoHKSE:02393 +4.55% Gross Margin % is 21.89% as of Jun. 2026, which is 17% above its 10-year median of 18.78. The stock has 4 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Yestar Healthcare Holdings Co ranks worse than 89.33% on this metric.
HKSE:02393's Gross Margin % is ranked worse than 89.33% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.44
vs HKSE:02393: 20.63
Yestar Healthcare Holdings Co had a gross margin of 21.89% for the quarter that ended in Jun. 2026 => Competition eroding margins
Yestar Healthcare Holdings Co (HKSE:02393) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Yestar Healthcare Holdings Co had a gross margin of 21.89% for the quarter that ended in Jun. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Yestar Healthcare Holdings Co Gross Margin % Related Terms
Yestar Healthcare Holdings Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yestar Healthcare Holdings Co Gross Margin % Chart
HKSE:02393 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Yestar Healthcare Holdings Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yestar Healthcare Holdings Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Yestar Healthcare Holdings Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Yestar Healthcare Holdings Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Yestar Healthcare Holdings Co (HKSE:02393) has a Gross Margin % of 21.89% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Yestar Healthcare Holdings Co and its competitors. This is 17% above median its historical median of 18.78. Over the past decade, Yestar Healthcare Holdings Co's Gross Margin % has ranged from 14.18 to 28.16. According to the industry distribution chart, Yestar Healthcare Holdings Co ranks #720 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 89.3%.
Is Yestar Healthcare Holdings Co's Gross Margin % too high?
Yestar Healthcare Holdings Co's current Gross Margin % of 21.89% is 17% above median its 10-year median of 18.78. Over the past 10 years, this metric has ranged from a low of 14.18 to a high of 28.16. The Medical Devices & Instruments industry median Gross Margin % is 52.44. Yestar Healthcare Holdings Co's value of 21.89% is 58.3% below this industry median. Based on the distribution chart, Yestar Healthcare Holdings Co ranks #720 out of 806 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Yestar Healthcare Holdings Co's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Yestar Healthcare Holdings Co ranks #720 out of 806 companies for Gross Margin %. This places Yestar Healthcare Holdings Co in the lower half of its industry. The industry median Gross Margin % is 52.44. Yestar Healthcare Holdings Co's value of 21.89% is 58.3% below this benchmark. Historically, Yestar Healthcare Holdings Co's own Gross Margin % has ranged from 14.18 to 28.16 over the past decade. While the company's 10-year median is 18.78 vs. the industry median of 52.44, Yestar Healthcare Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.44, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yestar Healthcare Holdings Co's current Gross Margin % of 21.89% is 58.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Yestar Healthcare Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yestar Healthcare Holdings Co's current Gross Margin % is 21.89%, which is 17% above median its own 10-year median of 18.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yestar Healthcare Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Yestar Healthcare Holdings Co (HKSE:02393) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.05, compared to a current price of HK$0.07 — trading 38% above its estimated fair value. The current Gross Margin % is 21.89%, which is 17% above median its 10-year median of 18.78 and 58.3% below the Medical Devices & Instruments industry median of 52.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Yestar Healthcare Holdings Co (HKSE:02393), the current Gross Margin % is 21.89% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yestar Healthcare Holdings Co Ltd is engaged in the manufacture, distribution, and sale of medical imaging products, distribution of In Vitro Diagnostic (IVD) products, and manufacture and sale of dental films. The Group has two reportable operating segments: Imaging printing products segment, which includes the manufacture and sale of colour photographic paper, industrial NDT x-ray films and PWB films, and trading of imaging equipment; and Medical products and equipment segment, which generates maximum revenue and includes manufacture and sale of medical dry films, medical wet films and dental films, and sale of medical equipment and diagnostic reagents. The Group operates its business in Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02393 has been successfully added to your 
